These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14677474)

  • 1. [Confusing drug information].
    Overø J
    Ugeskr Laeger; 2003 Nov; 165(48):4668; author reply 4668-9. PubMed ID: 14677474
    [No Abstract]   [Full Text] [Related]  

  • 2. [Generic preparations are a nuisance].
    Lyftingsmo S
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1802-3. PubMed ID: 17599134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Should we accept defective copies?].
    Ostholm I
    Lakartidningen; 1993 Oct; 90(43):3747-8. PubMed ID: 8231521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nevertheless control of documentation of generic drugs?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1669. PubMed ID: 17571110
    [No Abstract]   [Full Text] [Related]  

  • 5. [Swedish confusion about generic preparations].
    Furuskog P
    Lakartidningen; 2006 Mar 1-7; 103(9):668. PubMed ID: 16583550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generic preparations and name confusion].
    Nielsen J
    Ugeskr Laeger; 2004 May; 166(23):2273. PubMed ID: 15487531
    [No Abstract]   [Full Text] [Related]  

  • 7. Data protection: an anti-generic weapon.
    Prescrire Int; 2003 Dec; 12(68):235. PubMed ID: 14986701
    [No Abstract]   [Full Text] [Related]  

  • 8. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for dollar-saving generics.
    Harv Heart Lett; 2006 Dec; 17(4):6. PubMed ID: 17297672
    [No Abstract]   [Full Text] [Related]  

  • 11. White paper. The five myths of generic competition. A Pharma Matters report. March 2009.
    Drug News Perspect; 2009 Apr; 22(3):171-5. PubMed ID: 19440560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variable products information is a problem].
    Forslund L
    Lakartidningen; 2007 Aug 22-28; 104(34):2360. PubMed ID: 17907566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calculation of drug information necessity factor of generic drugs].
    Iijima H; Kurosaki T; Kamei M; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2003 Dec; 123(12):1039-47. PubMed ID: 14689867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
    Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
    Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wrong solution of a serious problem].
    Verland K
    Ugeskr Laeger; 2004 May; 166(20):1920. PubMed ID: 15202388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Generic preparations--undocumented effects?].
    Dyrkorn R
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2548; author reply 2548. PubMed ID: 17028644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Generic preparations--undocumented effects?].
    Høiseth A
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2985-6; author reply 2986. PubMed ID: 17117201
    [No Abstract]   [Full Text] [Related]  

  • 18. An Indian effort towards affordable drugs: "generic to designer drugs".
    Taneja B; Yadav J; Chakraborty TK; Brahmachari SK
    Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440
    [No Abstract]   [Full Text] [Related]  

  • 19. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Grice S
    N Z Bioeth J; 2003 Oct; 4(3):22-4. PubMed ID: 15597479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Where does publicity on drugs start?].
    Kurz C
    Soins; 1979 May; 24(10):2. PubMed ID: 256633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.